The metabolomic results suggested that insufficiency of AKR1A1 may lead to the accumulation of 3,4‐dihyroxybutyrate and glucoronate, key metabolites that predicted DKD in diabetic patients. Here, AKR1A1 is linked to diabetic kidney disease.